Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1989 Oct;28(4):373–387. doi: 10.1111/j.1365-2125.1989.tb03516.x

The increase in urinary excretion of 6 beta-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction.

C Ged 1, J M Rouillon 1, L Pichard 1, J Combalbert 1, N Bressot 1, P Bories 1, H Michel 1, P Beaune 1, P Maurel 1
PMCID: PMC1379986  PMID: 2590599

Abstract

1. Urinary excretion of 6 beta-hydroxycortisol, hepatic microsomal cortisol 6 beta-hydroxylase and the specific content of several forms of cytochrome P450 were measured in 8 to 14 patients before and after treatment with rifampicin (600 mg orally per day for 4 days). 2. Rifampicin treatment produced an average five fold increase in daily excretion of urinary 6 beta-hydroxycortisol. 3. Cortisol 6 beta-hydroxylase activity increased from 15 +/- 6 pmol min-1 mg-1 in organ donors (considered as 'control subjects') to 87 +/- 31 pmol min-1 mg-1 in rifampicin treated patients. 4. Among three forms of human P450 (P450IA, IIC and IIIA), (1), (2), measured by Western blots, only P450IIIA was significantly induced by the antibiotic. 5. Only antibodies against P450IIIA selectively inhibited cortisol 6 beta-hydroxylase in human liver microsomes. 6. Cortisol 6 beta-hydroxylase was correlated with P450IIIA specific content. 7. The urinary level of 6 beta-hydroxycortisol correlated with liver microsomal cortisol 6 beta-hydroxylase and P450IIIA specific content. 8. We conclude that P450IIIA is predominantly responsible for cortisol 6 beta-hydroxylase activity in human liver microsomes and that urinary 6 beta-hydroxycortisol is a marker of the induction of this cytochrome P450.

Full text

PDF
373

Images in this article

381Figure 2
on p.381

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beaune P. H., Guengerich F. P. Human drug metabolism in vitro. Pharmacol Ther. 1988;37(2):193–211. doi: 10.1016/0163-7258(88)90025-3. [DOI] [PubMed] [Google Scholar]
  2. Beaune P. H., Kremers P. G., Kaminsky L. S., De Graeve J., Albert A., Guengerich F. P. Comparison of monooxygenase activities and cytochrome P-450 isozyme concentrations in human liver microsomes. Drug Metab Dispos. 1986 Jul-Aug;14(4):437–442. [PubMed] [Google Scholar]
  3. Beaune P. H., Umbenhauer D. R., Bork R. W., Lloyd R. S., Guengerich F. P. Isolation and sequence determination of a cDNA clone related to human cytochrome P-450 nifedipine oxidase. Proc Natl Acad Sci U S A. 1986 Nov;83(21):8064–8068. doi: 10.1073/pnas.83.21.8064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Beaune P., Kremers P., Letawe-Goujon F., Gielen J. E. Monoclonal antibodies against human liver cytochrome P-450. Biochem Pharmacol. 1985 Oct 1;34(19):3547–3552. doi: 10.1016/0006-2952(85)90732-4. [DOI] [PubMed] [Google Scholar]
  5. Bonfils C., Dalet-Beluche I., Maurel P. Triacetyloleandomycin as inducer of cytochrome P-450 LM3c from rabbit liver microsomes. Biochem Pharmacol. 1985 Jul 15;34(14):2445–2450. doi: 10.1016/0006-2952(85)90524-6. [DOI] [PubMed] [Google Scholar]
  6. Burke M. D., Mayer R. T. Ethoxyresorufin: direct fluorimetric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene. Drug Metab Dispos. 1974 Nov-Dec;2(6):583–588. [PubMed] [Google Scholar]
  7. Combalbert J., Fabre I., Fabre G., Dalet I., Derancourt J., Cano J. P., Maurel P. Metabolism of cyclosporin A. IV. Purification and identification of the rifampicin-inducible human liver cytochrome P-450 (cyclosporin A oxidase) as a product of P450IIIA gene subfamily. Drug Metab Dispos. 1989 Mar-Apr;17(2):197–207. [PubMed] [Google Scholar]
  8. Cresteil T., Beaune P., Kremers P., Celier C., Guengerich F. P., Leroux J. P. Immunoquantification of epoxide hydrolase and cytochrome P-450 isozymes in fetal and adult human liver microsomes. Eur J Biochem. 1985 Sep 2;151(2):345–350. doi: 10.1111/j.1432-1033.1985.tb09107.x. [DOI] [PubMed] [Google Scholar]
  9. Dalet C., Clair P., Daujat M., Fort P., Blanchard J. M., Maurel P. Complete sequence of cytochrome P450 3c cDNA and presence of two mRNA species with 3' untranslated regions of different lengths. DNA. 1988 Jan-Feb;7(1):39–46. doi: 10.1089/dna.1988.7.39. [DOI] [PubMed] [Google Scholar]
  10. Daujat M., Pichard L., Dalet C., Larroque C., Bonfils C., Pompon D., Li D., Guzelian P. S., Maurel P. Expression of five forms of microsomal cytochrome P-450 in primary cultures of rabbit hepatocytes treated with various classes of inducers. Biochem Pharmacol. 1987 Nov 1;36(21):3597–3606. doi: 10.1016/0006-2952(87)90008-6. [DOI] [PubMed] [Google Scholar]
  11. Desager J. P., Dumont E., Harvengt C. The urinary 6 beta-hydroxycortisol excretion in man on inducers and inhibitors of the hepatic mixed function oxidase. Pharmacol Ther. 1987;33(1):197–199. doi: 10.1016/0163-7258(87)90051-9. [DOI] [PubMed] [Google Scholar]
  12. Distlerath L. M., Reilly P. E., Martin M. V., Davis G. G., Wilkinson G. R., Guengerich F. P. Purification and characterization of the human liver cytochromes P-450 involved in debrisoquine 4-hydroxylation and phenacetin O-deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism. J Biol Chem. 1985 Jul 25;260(15):9057–9067. [PubMed] [Google Scholar]
  13. FRANTZ A. G., KATZ F. H., JAILER J. W. 6beta-Hydroxycortisol and other polar corticosteroids: measurement and significance in human urine. J Clin Endocrinol Metab. 1961 Oct;21:1290–1303. doi: 10.1210/jcem-21-10-1290. [DOI] [PubMed] [Google Scholar]
  14. Fabre G., Crevat-Pisano P., Dragna S., Covo J., Barra Y., Cano J. P. Involvement of the macrolide antibiotic inducible cytochrome P-450 LM3c in the metabolism of midazolam by microsomal fractions prepared from rabbit liver. Biochem Pharmacol. 1988 May 15;37(10):1947–1953. doi: 10.1016/0006-2952(88)90541-2. [DOI] [PubMed] [Google Scholar]
  15. Ged C., Umbenhauer D. R., Bellew T. M., Bork R. W., Srivastava P. K., Shinriki N., Lloyd R. S., Guengerich F. P. Characterization of cDNAs, mRNAs, and proteins related to human liver microsomal cytochrome P-450 (S)-mephenytoin 4'-hydroxylase. Biochemistry. 1988 Sep 6;27(18):6929–6940. doi: 10.1021/bi00418a039. [DOI] [PubMed] [Google Scholar]
  16. Gonzalez F. J., Skoda R. C., Kimura S., Umeno M., Zanger U. M., Nebert D. W., Gelboin H. V., Hardwick J. P., Meyer U. A. Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature. 1988 Feb 4;331(6155):442–446. doi: 10.1038/331442a0. [DOI] [PubMed] [Google Scholar]
  17. Guengerich F. P., Dannan G. A., Wright S. T., Martin M. V., Kaminsky L. S. Purification and characterization of liver microsomal cytochromes p-450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or beta-naphthoflavone. Biochemistry. 1982 Nov 9;21(23):6019–6030. doi: 10.1021/bi00266a045. [DOI] [PubMed] [Google Scholar]
  18. Guengerich F. P., Martin M. V., Beaune P. H., Kremers P., Wolff T., Waxman D. J. Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. J Biol Chem. 1986 Apr 15;261(11):5051–5060. [PubMed] [Google Scholar]
  19. Guengerich F. P. Oxidation of 17 alpha-ethynylestradiol by human liver cytochrome P-450. Mol Pharmacol. 1988 May;33(5):500–508. [PubMed] [Google Scholar]
  20. Guengerich F. P., Wang P., Davidson N. K. Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits, and humans using immunochemical staining coupled with sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Biochemistry. 1982 Mar 30;21(7):1698–1706. doi: 10.1021/bi00536a035. [DOI] [PubMed] [Google Scholar]
  21. Haugen D. A., Coon M. J. Properties of electrophoretically homogeneous phenobarbital-inducible and beta-naphthoflavone-inducible forms of liver microsomal cytochrome P-450. J Biol Chem. 1976 Dec 25;251(24):7929–7939. [PubMed] [Google Scholar]
  22. Heinemeyer G., Roots I., Lestau P., Klaiber H. R., Dennhardt R. D-glucaric acid excretion in critical care patients--comparison with 6 beta-hydroxycortisol excretion and serum gamma-glutamyltranspeptidase activity and relation to multiple drug therapy. Br J Clin Pharmacol. 1986 Jan;21(1):9–18. doi: 10.1111/j.1365-2125.1986.tb02817.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Hosoda H., Sakai Y., Nambara T. A direct enzyme immunoassay of 6 beta-hydroxycortisol in human urine. Chem Pharm Bull (Tokyo) 1981 Jan;29(1):170–175. doi: 10.1248/cpb.29.170. [DOI] [PubMed] [Google Scholar]
  24. Jaiswal A. K., Gonzalez F. J., Nebert D. W. Human P1-450 gene sequence and correlation of mRNA with genetic differences in benzo[a]pyrene metabolism. Nucleic Acids Res. 1985 Jun 25;13(12):4503–4520. doi: 10.1093/nar/13.12.4503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Jaiswal A. K., Gonzalez F. J., Nebert D. W. Human dioxin-inducible cytochrome P1-450: complementary DNA and amino acid sequence. Science. 1985 Apr 5;228(4695):80–83. doi: 10.1126/science.3838385. [DOI] [PubMed] [Google Scholar]
  26. KATZ F. H., LIPMAN M. M., FRANTZ A. G., JAILER J. W. The physiologic significance of 6beta-hydroxycortisol in human corticoid metabolism. J Clin Endocrinol Metab. 1962 Jan;22:71–77. doi: 10.1210/jcem-22-1-71. [DOI] [PubMed] [Google Scholar]
  27. Kawajiri K., Watanabe J., Gotoh O., Tagashira Y., Sogawa K., Fujii-Kuriyama Y. Structure and drug inducibility of the human cytochrome P-450c gene. Eur J Biochem. 1986 Sep 1;159(2):219–225. doi: 10.1111/j.1432-1033.1986.tb09857.x. [DOI] [PubMed] [Google Scholar]
  28. Kishida S., Fukushima D. K. Radioimmunoassay of 6beta-hydroxycortisol in human plasma and urine. Steroids. 1977 Dec;30(6):741–749. doi: 10.1016/s0039-128x(77)80020-2. [DOI] [PubMed] [Google Scholar]
  29. Kleinbloesem C. H., van Brummelen P., Faber H., Danhof M., Vermeulen N. P., Breimer D. D. Variability in nifedipine pharmacokinetics and dynamics: a new oxidation polymorphism in man. Biochem Pharmacol. 1984 Nov 15;33(22):3721–3724. doi: 10.1016/0006-2952(84)90165-5. [DOI] [PubMed] [Google Scholar]
  30. Kremers P., Beaune P., Cresteil T., de Graeve J., Columelli S., Leroux J. P., Gielen J. E. Cytochrome P-450 monooxygenase activities in human and rat liver microsomes. Eur J Biochem. 1981 Sep 1;118(3):599–606. doi: 10.1111/j.1432-1033.1981.tb05561.x. [DOI] [PubMed] [Google Scholar]
  31. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  32. Le Provost E., Flinois J. P., Beaune P., Leroux J. P. Immunochemical characterization of some monooxygenase activities in liver microsomes from untreated and phenobarbital-treated rats. Biochem Biophys Res Commun. 1981 Jul 30;101(2):547–554. doi: 10.1016/0006-291x(81)91294-8. [DOI] [PubMed] [Google Scholar]
  33. Miles J. S., Spurr N. K., Gough A. C., Jowett T., McLaren A. W., Brook J. D., Wolf C. R. A novel human cytochrome P450 gene (P450IIB): chromosomal localization and evidence for alternative splicing. Nucleic Acids Res. 1988 Jul 11;16(13):5783–5795. doi: 10.1093/nar/16.13.5783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Molowa D. T., Schuetz E. G., Wrighton S. A., Watkins P. B., Kremers P., Mendez-Picon G., Parker G. A., Guzelian P. S. Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liver. Proc Natl Acad Sci U S A. 1986 Jul;83(14):5311–5315. doi: 10.1073/pnas.83.14.5311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Moreland T. A., Park B. K., Rylance G. W. Microsomal enzyme induction in children: the influence of carbamazepine treatment on antipyrine kinetics, 6 beta-hydroxycortisol excretion and plasma gamma-glutamyltranspeptidase activity. Br J Clin Pharmacol. 1982 Dec;14(6):861–865. doi: 10.1111/j.1365-2125.1982.tb02050.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Murphy B. E. Clinical evaluation of urinary cortisol determinations by competetive protein-binding radioassay. J Clin Endocrinol Metab. 1968 Mar;28(3):343–348. doi: 10.1210/jcem-28-3-343. [DOI] [PubMed] [Google Scholar]
  37. Nahoul K., Adeline J., Paysant F., Scholler R. Radioimmunoassay of plasma and urine 6 beta-hydroxycortisol: levels in healthy adults and in hypercortisolemic states. J Steroid Biochem. 1982 Sep;17(3):343–350. doi: 10.1016/0022-4731(82)90209-6. [DOI] [PubMed] [Google Scholar]
  38. Nakamura J., Yakata M. Determination of urinary cortisol and 6 beta-hydroxycortisol by high performance liquid chromatography. Clin Chim Acta. 1985 Jul 15;149(2-3):215–224. doi: 10.1016/0009-8981(85)90335-3. [DOI] [PubMed] [Google Scholar]
  39. Nebert D. W., Gonzalez F. J. P450 genes: structure, evolution, and regulation. Annu Rev Biochem. 1987;56:945–993. doi: 10.1146/annurev.bi.56.070187.004501. [DOI] [PubMed] [Google Scholar]
  40. Nebert D. W., Nelson D. R., Adesnik M., Coon M. J., Estabrook R. W., Gonzalez F. J., Guengerich F. P., Gunsalus I. C., Johnson E. F., Kemper B. The P450 superfamily: updated listing of all genes and recommended nomenclature for the chromosomal loci. DNA. 1989 Jan-Feb;8(1):1–13. doi: 10.1089/dna.1.1989.8.1. [DOI] [PubMed] [Google Scholar]
  41. Ohnhaus E. E., Gerber-Taras E., Park B. K. Enzyme-inducing drug combinations and their effects on liver microsomal enzyme activity in man. Eur J Clin Pharmacol. 1983;24(2):247–250. doi: 10.1007/BF00613826. [DOI] [PubMed] [Google Scholar]
  42. Okino S. T., Quattrochi L. C., Pendurthi U. R., McBride O. W., Tukey R. H. Characterization of multiple human cytochrome P-450 1 cDNAs. The chromosomal localization of the gene and evidence for alternate RNA splicing. J Biol Chem. 1987 Nov 25;262(33):16072–16079. [PubMed] [Google Scholar]
  43. Park B. K. A direct radioimmunoassay for 6 beta-hydroxycortisol in human urine. J Steroid Biochem. 1978 Oct;9(10):963–966. doi: 10.1016/0022-4731(78)90058-4. [DOI] [PubMed] [Google Scholar]
  44. Park B. K. Assessment of the drug metabolism capacity of the liver. Br J Clin Pharmacol. 1982 Nov;14(5):631–651. doi: 10.1111/j.1365-2125.1982.tb04950.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Park B. K. Assessment of urinary 6 beta-hydroxycortisol as an in vivo index of mixed-function oxygenase activity. Br J Clin Pharmacol. 1981 Aug;12(2):97–102. doi: 10.1111/j.1365-2125.1981.tb01186.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Park B. K., Eichelbaum M., Ohnhaus E. E. 6 beta-hydroxycortisol excretion in relation to polymorphic N-oxidation of sparteine. Br J Clin Pharmacol. 1982 May;13(5):737–740. doi: 10.1111/j.1365-2125.1982.tb01448.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Perucca E., Grimaldi R., Frigo G. M., Sardi A., Mönig H., Ohnhaus E. E. Comparative effects of rifabutin and rifampicin on hepatic microsomal enzyme activity in normal subjects. Eur J Clin Pharmacol. 1988;34(6):595–599. doi: 10.1007/BF00615223. [DOI] [PubMed] [Google Scholar]
  48. Phillips I. R., Shephard E. A., Ashworth A., Rabin B. R. Isolation and sequence of a human cytochrome P-450 cDNA clone. Proc Natl Acad Sci U S A. 1985 Feb;82(4):983–987. doi: 10.1073/pnas.82.4.983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Quattrochi L. C., Pendurthi U. R., Okino S. T., Potenza C., Tukey R. H. Human cytochrome P-450 4 mRNA and gene: part of a multigene family that contains Alu sequences in its mRNA. Proc Natl Acad Sci U S A. 1986 Sep;83(18):6731–6735. doi: 10.1073/pnas.83.18.6731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Roots I., Holbe R., Hövermann W., Nigam S., Heinemeyer G., Hildebrandt A. G. Quantitative determination by HPLC of urinary 6beta-hydroxycortisol, an indicator of enzyme induction by rifampicin and antiepileptic drugs. Eur J Clin Pharmacol. 1979 Aug;16(1):63–71. doi: 10.1007/BF00644969. [DOI] [PubMed] [Google Scholar]
  51. Saenger P. 6 beta-hydroxycortisol in random urine samples as an indicator of enzyme induction. Clin Pharmacol Ther. 1983 Dec;34(6):818–821. doi: 10.1038/clpt.1983.255. [DOI] [PubMed] [Google Scholar]
  52. Saenger P., Forster E., Kream J. 6 beta-Hydroxycortisol: a noninvasive indicator of enzyme induction. J Clin Endocrinol Metab. 1981 Mar;52(3):381–384. doi: 10.1210/jcem-52-3-381. [DOI] [PubMed] [Google Scholar]
  53. Shimada T., Misono K. S., Guengerich F. P. Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction. J Biol Chem. 1986 Jan 15;261(2):909–921. [PubMed] [Google Scholar]
  54. Song B. J., Gelboin H. V., Park S. S., Yang C. S., Gonzalez F. J. Complementary DNA and protein sequences of ethanol-inducible rat and human cytochrome P-450s. Transcriptional and post-transcriptional regulation of the rat enzyme. J Biol Chem. 1986 Dec 15;261(35):16689–16697. [PubMed] [Google Scholar]
  55. Umbenhauer D. R., Martin M. V., Lloyd R. S., Guengerich F. P. Cloning and sequence determination of a complementary DNA related to human liver microsomal cytochrome P-450 S-mephenytoin 4-hydroxylase. Biochemistry. 1987 Feb 24;26(4):1094–1099. doi: 10.1021/bi00378a016. [DOI] [PubMed] [Google Scholar]
  56. Van Cantfort J., De Graeve J., Gielen J. E. Radioactive assay for aryl hydrocarbon hydroxylase. Improved method and biological importance. Biochem Biophys Res Commun. 1977 Nov 21;79(2):505–512. doi: 10.1016/0006-291x(77)90186-3. [DOI] [PubMed] [Google Scholar]
  57. Vestal R. E., Cusack B. J., Mercer G. D., Dawson G. W., Park B. K. Aging and drug interactions. I. Effect of cimetidine and smoking on the oxidation of theophylline and cortisol in healthy men. J Pharmacol Exp Ther. 1987 May;241(2):488–500. [PubMed] [Google Scholar]
  58. Wang P. P., Beaune P., Kaminsky L. S., Dannan G. A., Kadlubar F. F., Larrey D., Guengerich F. P. Purification and characterization of six cytochrome P-450 isozymes from human liver microsomes. Biochemistry. 1983 Nov 8;22(23):5375–5383. doi: 10.1021/bi00292a019. [DOI] [PubMed] [Google Scholar]
  59. Watkins P. B., Wrighton S. A., Maurel P., Schuetz E. G., Mendez-Picon G., Parker G. A., Guzelian P. S. Identification of an inducible form of cytochrome P-450 in human liver. Proc Natl Acad Sci U S A. 1985 Sep;82(18):6310–6314. doi: 10.1073/pnas.82.18.6310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Waxman D. J., Attisano C., Guengerich F. P., Lapenson D. P. Human liver microsomal steroid metabolism: identification of the major microsomal steroid hormone 6 beta-hydroxylase cytochrome P-450 enzyme. Arch Biochem Biophys. 1988 Jun;263(2):424–436. doi: 10.1016/0003-9861(88)90655-8. [DOI] [PubMed] [Google Scholar]
  61. Wrighton S. A., Thomas P. E., Molowa D. T., Haniu M., Shively J. E., Maines S. L., Watkins P. B., Parker G., Mendez-Picon G., Levin W. Characterization of ethanol-inducible human liver N-nitrosodimethylamine demethylase. Biochemistry. 1986 Nov 4;25(22):6731–6735. doi: 10.1021/bi00370a001. [DOI] [PubMed] [Google Scholar]
  62. Wrighton S. A., Thomas P. E., Ryan D. E., Levin W. Purification and characterization of ethanol-inducible human hepatic cytochrome P-450HLj. Arch Biochem Biophys. 1987 Oct;258(1):292–297. doi: 10.1016/0003-9861(87)90347-x. [DOI] [PubMed] [Google Scholar]
  63. Zhiri A., Wellman-Bednawska M., Siest G. ELISA of 6-beta-hydroxycortisol in human urine: diurnal variations and effects of antiepileptic therapy. Clin Chim Acta. 1986 Jun 30;157(3):267–276. doi: 10.1016/0009-8981(86)90302-5. [DOI] [PubMed] [Google Scholar]
  64. Zhiri A., Wellman-Bednawska M., Siest G. Le 6-beta-hydroxycortisol: un reflet non invasif des enzymes du métabolisme des médicaments. Pathol Biol (Paris) 1987 Sep;35(7):1087–1093. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES